Ceridian HCM Holding Inc at Credit Suisse Technology Conference Transcript

Nov 29, 2022 / 03:55PM GMT
Kevin Damien McVeigh - Crédit Suisse AG - Research Division - MD

Thank you. Thank you all for taking time out of your schedules today. I'm just going to do a quick introduction to David Ossip and then sit down. We're thrilled to have Ceridian here today. David Ossip, CEO.

I'm Kevin McVeigh. By way of background, I'm the Credit Suisse HCM analyst. I've been at CS about 5 years now covering the sector more broadly for about 20 years.

Really, really thrilled to have Ceridian here. I think David is one of the real visionaries in the industry. What I want to do is try to keep this as open as possible. I'm going to sit down, start out with a couple of questions and then really weave it into you folks as well to try to keep this as collaborative, but we've got plenty of questions. So David, thank you again.

Questions and Answers:

Kevin Damien McVeigh - Crédit Suisse AG - Research Division - MD

What I wanted to start with, and it may sound a little basic, but Ceridian has differentiated
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot